Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia

被引：0

作者：

Pullarkat, Vinod ^{[1
,2
]}

Pratz, Keith W. ^{[3
]}

Doehner, Hartmut ^{[4
]}

Recher, Christian ^{[5
]}

Thirman, Michael J. ^{[6
]}

Dinardo, Courtney D.

Fenaux, Pierre ^{[8
,9
]}

Schuh, Andre C. ^{[10
]}

Wei, Andrew H. ^{[11
,12
]}

Pigneux, Arnaud ^{[13
]}

Jang, Jun-Ho ^{[14
]}

Juliusson, Gunnar ^{[15
]}

Miyazaki, Yasushi ^{[16
]}

Selleslag, Dominik ^{[17
]}

Arellano, Martha L. ^{[18
]}

Liu, Chenglong ^{[19
]}

Ridgeway, Jean A. ^{[19
]}

Potluri, Jalaja ^{[19
]}

Schuler, Jovita ^{[19
]}

Konopleva, Marina ^{[7
]}

机构：

[1] City Hope Comprehens Canc Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA

[2] City Hope Comprehens Canc Ctr, Gehr Family Ctr Leukemia Res, Duarte, CA 91010 USA

[3] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA

[4] Ulm Univ Hosp, Dept Internal Med 3, Ulm, Germany

[5] CHU Toulouse, Toulouse, France

[6] Univ Chicago Med, Dept Med, Sect Hematol Oncol, Chicago, IL USA

[7] Montefiore Einstein Comprehens Canc Ctr, Bronx, NY USA

[8] Hop St Louis, Assistance Publ Hop Paris, Paris, France

[9] Univ Paris, Paris, France

[10] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada

[11] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Peter MacCallum Canc Ctr, Melbourne, VIC, Australia

[12] Univ Melbourne, Melbourne, VIC, Australia

[13] CHU Bordeaux, Dept Hematol, Bordeaux, France

[14] Sungkyunkwan Univ, Samsung Med Ctr, Dept Hematol Oncol, Sch Med, Seoul, South Korea

[15] Skane Univ Hosp, Dept Hematol, Lund, Sweden

[16] Nagasaki Univ, Atom Bomb Dis Inst, Dept Hematol, Atom Bomb Dis & Hibakusha Med Unit, Nagasaki, Japan

[17] Algemeen Ziekenhuis St Jan, Brugge, Belgium

[18] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA USA

[19] AbbVie Inc, N Chicago, IL USA

来源：

BLOOD CANCER JOURNAL | 2025年 / 15卷 / 01期

关键词：

D O I：

10.1038/s41408-025-01263-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：5

共 50 条

[21] Therapy-related myelodysplastic syndrome and acute myeloid leukemia in patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide
Colovic, M.
Suvajdzic, N.
Jankovic, G.
Tomin, D.
Colovic, N.
Fekete, M. Dencic
Palibrk, V.
BIOMEDICINE & PHARMACOTHERAPY, 2011, 65 (05) : 319 - 321
[22] TREATMENT OF THERAPY-RELATED ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
BALLEN, KK
ANTIN, JH
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1993, 7 (02) : 477 - 493
[23] Predictive Model for Infection Risk in Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Patients Treated With Azacitidine; Azacitidine Infection Risk Model: The Polish Adult Leukemia Group Study
Madry, Krzysztof
Lis, Karol
Biecek, Przemyslaw
Mlynarczyk, Magda
Rytel, Agoda
Gorka, Michal
KacFrzyk, Piotr
Dutka, Magdalena
Rodzaj, Marek
Bolkun, Lukasz
Krochmalczyk, Dorota
Latka, Ewa
Drozd-Sokolowska, Joanna
Waszczuk-Gajda, Anna
Knopinska-Posluszny, Wanda
Kopinska, Anna
Subocz, Edyta
Masternak, Anna
Guzicka-Kazimierczak, Renata
Gil, Lidia
Machowicz, Rafal
Bilinski, Jaroslaw
Giebe, Sebastian
Czerw, Tomasz
Dwilewicz-Trojaczek, Jadwiga
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (05) : 264 - +
[24] Therapy-Related Trilineage Mixed Phenotype Acute Leukemia Treated with Venetoclax and Azacitidine
Yamamoto, Jotaro
Yamaguchi, Kyosuke
Watanabe, Otoya
Kageyama, Kosei
Taya, Yuki
Kaji, Daisuke
Nishida, Aya
Uruga, Hironori
Takagi, Shinsuke
Ishiwata, Kazuya
Yamamoto, Hisashi
Masuda, Akiko
Takazawa, Yutaka
Yamamoto, Go
Mori, Yuki
Uchida, Naoyuki
Wake, Atsushi
INTERNAL MEDICINE, 2025,
[25] Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
Xia, Leiming
Tian, Wanlu
Zhao, Yiming
Jiang, Lingling
Qian, Wei
Jiang, Lei
Ge, Ling
Li, Jianjun
Jin, Fengbo
Yang, Mingzhen
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
[26] Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
Leiming Xia
Wanlu Tian
Yiming Zhao
Lingling Jiang
Wei Qian
Lei Jiang
Ling Ge
Jianjun Li
Fengbo Jin
Mingzhen Yang
Signal Transduction and Targeted Therapy, 8
[27] Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes
Voso, MT
Scardocci, A
Guidi, F
Zini, G
Di Mario, A
Pagano, L
Hohaus, S
Leone, G
BLOOD, 2004, 103 (02) : 698 - 700
[28] Azacytidine and Vorinostat in Patients with Chronic Lymphocytic Leukemia (CLL) Diagnosed with Therapy-Related Myelodysplastic Syndromes/Acute Myeloid Leukemia (t-MDS/AML)
Alvarado, Yesid
Keating, Michael J.
O'Brien, Susan
Kantarjian, Hagop M.
Wierda, William G.
Sneed, Troy
Jain, Nitin
Garcia-Manero, Guillermo
BLOOD, 2014, 124 (21)
[29] IMPACT OF AZACITIDINE TREATMENT ON INFECTIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA, MYELODYSPLASTIC SYNDROMES AND MYELODYSPLASTIC/MYELOPROLIFERATIVE SYNDROMES
Villegas, C.
Ortiz, S.
Javier, K.
Costa, S.
Ivars, D.
Collado, R.
Lopez, M.
Irene, L.
Roig, M.
Sanchez, M.
Perez, P.
Orero, M.
HAEMATOLOGICA, 2016, 101 : 483 - 483
[30] Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia
Winters, Amanda C.
Gutman, Jonathan A.
Purev, Enkhtsetseg
Nakic, Molly
Tobin, Jennifer
Chase, Stephanie
Kaiser, Jeff
Lyle, Lindsey
Boggs, Chelsey
Halsema, Keri
Schowinsky, Jeffrey T.
Rosser, Julie
Ewalt, Mark D.
Siegele, Bradford
Rana, Vishal
Schuster, Steven
Abbott, Diana
Stevens, Brett M.
Jordan, Craig T.
Smith, Clayton
Pollyea, Daniel A.
BLOOD ADVANCES, 2019, 3 (20) : 2911 - 2919

← 1 2 3 4 5 →